ARTICLE | Company News
Endo in-licenses Alexza's AZ-003
December 28, 2007 1:43 AM UTC
ALXA granted ENDP exclusive rights to develop and commercialize Staccato fentanyl ( AZ-003) in North America. The product, which uses ALXA's Staccato system inhaler to deliver fentanyl, is in Phase I ...